VanEck Vectors Valuation Overview

BBH -- USA Etf  

USD 127.86  0.83  0.65%

VanEck Vectors Biotech has current Real Value of $137.96 per share. The regular price of the etf is $127.86. At this time the etf appears to be under valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 10.64% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is the top ETF in price to earning as compared to similar ETFs. It is the top ETF in one year return as compared to similar ETFs reporting about  0.06  of One Year Return per Price to Earning. The ratio of Price to Earning to One Year Return for VanEck Vectors Biotech ETF is roughly  16.50 

Current Market Valuation

VanEck Vectors Biotech Valuation Boundaries
Under Valued
July 16, 2018
127.86
Market Value
Downside
115.18
137.96
Real Value
Target Odds
  
141.53
Upside
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 1 month time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.